DB
DMC Biotechnologies, Inc.
SEC filingBiotechnology · Boulder, CO
Amount raised$905Ksold at filing
Total offering$1.7M$754K still open
Investors in the raise4count reported to the SEC
FiledDec 30, 2025first sale Oct 31, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Rob van der MeijDirector
Josh YelenExecutive Officer
Alastair CooperDirector
K'Lynne JohnsonDirector
Matthew LipscombDirector
Jim FlattExecutive Officer, Director
Doug CameronDirector
Josko BobanovicDirector
Executive officers, directors and promoters as listed on the Form D.